1. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17, 187 cases of suspected acute myocardial infarction: ISIS-2;ISIS-2 (Second International Study of Infarct Survival) Collaborative Group;Lancet,1988
2. Effect of intravenous APSAC on mortality after acute myocardial infarction: Preliminary report of a placebo-controlled trial;Aims Trial Study Group;Lancet,1988
3. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction: Anglo-Scandinavian Study of Early Thrombolysis (ASSET);Wilcox;Lancet,1988
4. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction;Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI);Lancet,1986
5. Long-term effects of intravenous thrombolysis in acute myocardial infarction: Final report of the GISSI study;Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI);Lancet,1987